DURHAM — Health Decisions Inc. has raised $1.8 million from 13 investors, according to Securities and Exchange Commission filing.
Health Decisions
The investment will allow the Durham-based company to continue to provide clinical development expertise for women’s health with minimal risk.
Health Decisions is a contract research organization. It’s committed to clinical research services, biostatistics and strategic consulting. The company has a dual focus that specializes in women’s health therapeutic clinical studies and studies diagnostics of all therapeutic areas.
The company was founded in 1989 by Michael Rosenberg, who died in a plane crash in 2014.
Chief Executive Officer Patrick Phillips has redoubled the company’s focus on women’s health and has expanded its focus on a wider range of products that address health care needs.
Phillips previously served as the company’s vice president of clinical affairs. He has been in the medical field and worked for CROs for more than 23 years, and led oversight and optional delivery on more than 200 regional and global clinical development projects.
He received his BSc in biochemistry from Liverpool University and a Ph.D. in clinical biochemistry from the University of Oxford in England.
The SEC filing can be found online.
This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism
